Disease | retinal detachment |
Phenotype | C0030343|panuveitis |
Sentences | 11 |
PubMedID- 23964873 | Vogt-koyanagi-harada (vkh) syndrome is a multisystemic disease characterized by granulomatous panuveitis with exsudative retinal detachment and often associated with neurological and skin symptomatology. |
PubMedID- 26469238 | panuveitis with exudative retinal detachments after vaccination against human papilloma virus. |
PubMedID- 20482392 | Conclusions: orbital malt lymphoma can masquerade as refractory unilateral panuveitis with exudative retinal detachment and appears to respond to a combination of radiotherapy and specific b-cell-targeted systemic therapy. |
PubMedID- 23514226 | 8 (recalcitrant panuveitis with rhegmatogenous retinal detachment) underwent pars plana vitrectomy with internal tamponade. |
PubMedID- 25125216 | The mean (sd) time until the appearance of ocular signs was 5.6 (2.3) months (range, 19 days to 7 months), and inflammation ranged from mild or low-grade anterior uveitis to severe explosive panuveitis complicated by retinal detachment. |
PubMedID- 22943816 | Bilateral granulomatous panuveitis with serous retinal detachments are the typical ocular findings. |
PubMedID- 21505533 | The patient had bilateral panuveitis with exudative retinal detachment associated with tonic pupils. |
PubMedID- 24734166 | Ocular manifestations are characterized by bilateral granulomatous panuveitis with exudative retinal detachments. |
PubMedID- 26509089 | A 50-year-old woman with a 20-year history of panuveitis associated with exudative retinal detachment in the left eye (le) that had been treated with long-term oral corticosteroids was referred to our center. |
PubMedID- 24019391 | Ophthalmologic examination revealed panuveitis with bilateral serous retinal detachments (figure 1) characteristic of vogt-koyanagi-harada (vkh) syndrome. |
PubMedID- 24763751 | Vogt-koyanagi-harada disease (vkhd) is a multisystemic disorder characterized by granulomatous panuveitis with exudative retinal detachments, often associated with neurologic and cutaneous manifestations. |
Page: 1